Clinical trials
Completed Hodgkin Disease trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2018 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 6 |
| Novartis Pharmaceuticals | 3 |
| Bayside Health | 2 |
| Accenture | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
| Pfizer | 1 |
| Takeda | 1 |
| The Canadian Blood and Marrow Transplant Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 18 |
| Lymphoma | 9 |
| Lymphoma, Non-Hodgkin | 6 |
| Recurrence | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, T-Cell, Cutaneous | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.